Based on the Wall Street analyst consensus for 193 of GB:SBIO’s holdings.
GB:SBIO 12 Month Forecast
Average Price Target
$97.48▲(0.00% Upside)
Based on Wall Street analyst 12-month price targets for 193 of Invesco NASDAQ Biotech UCITS ETF’s holdings in the last 3 months. The average price target is $97.48 with a high forecast of $125.47 and a low forecast of $72.33. The average price target represents a ― change from the last price of ―.
What is GB:SBIO’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 193 of GB:SBIO’s holdings, Invesco NASDAQ Biotech UCITS ETF’s 12-month average price target is $97.48.
Is GB:SBIO a Buy, Sell or Hold?
Invesco NASDAQ Biotech UCITS ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 193 of GB:SBIO’s holdings: 163 rated Buy, 29 rated Hold and 1 rated Sell.
What is Invesco NASDAQ Biotech UCITS ETF’s price target?
The average price target for Invesco NASDAQ Biotech UCITS ETF is $97.48, based on Wall Street analyst 12-month price targets for 193 of GB:SBIO’s holdings, issued in the past 3 months. The highest price target is $125.47 and the lowest is $72.33.
How many holdings does GB:SBIO have?
GB:SBIO holds 268 assets.
How can I buy shares of GB:SBIO?
You can buy shares of GB:SBIO through a brokerage account. Compare brokers on our Best Online Brokers page.